Jiancheng Guo Selected Research

Antioxidants

1/2021	Treatment of Acute Kidney Injury Using a Dual Enzyme Embedded Zeolitic Imidazolate Frameworks Cascade That Catalyzes In Vivo Reactive Oxygen Species Scavenging.
11/2020	Development of a novel oxidative stress-amplifying nanocomposite capable of supplying intratumoral H2O2 and O2 for enhanced chemodynamic therapy and radiotherapy in patient-derived xenograft (PDX) models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jiancheng Guo Research Topics

Disease

7	Neoplasms (Cancer) 07/2022 - 06/2013
2	Hypoxia (Hypoxemia) 01/2021 - 11/2020
2	Albuminuria 05/2008 - 04/2003
2	Hyperglycemia 06/2005 - 05/2003
1	Squamous Cell Carcinoma of Head and Neck 03/2022
1	Chronic Kidney Failure (Chronic Renal Failure) 07/2021
1	Kidney Diseases (Kidney Disease) 07/2021
1	Acute Kidney Injury (Acute Renal Failure) 01/2021
1	COVID-19 01/2020
1	Fatigue 01/2020
1	Hypersensitivity (Allergy) 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2019
1	Myofibroma 06/2013
1	Myofibromatosis 06/2013
1	Waardenburg Syndrome (Klein Syndrome) 07/2011
1	Spinal Muscular Atrophy (Progressive Muscular Atrophy) 10/2010
1	Nephrosis 05/2008
1	Nephrotic Syndrome (Syndrome, Nephrotic) 05/2008
1	Macular Degeneration (Age-Related Maculopathy) 03/2007
1	Diabetic Nephropathies (Diabetic Nephropathy) 05/2003

Drug/Important Bio-Agent (IBA)

3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020 - 04/2003
2	RNA (Ribonucleic Acid)IBA 03/2022 - 06/2013
2	Biomarkers (Surrogate Marker)IBA 03/2022 - 01/2020
2	EnzymesIBA 01/2021 - 11/2020
2	AntioxidantsIBA 01/2021 - 11/2020
2	LigandsIBA 06/2005 - 05/2003
1	CarbonIBA 07/2022
1	CamptothecinIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Oxygen (Dioxygen)IBA 01/2021
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	PapaverineIBA 01/2021
1	ThymosinIBA 11/2020
1	Immunologic Factors (Immunomodulators)IBA 11/2020
1	VaccinesIBA 01/2020
1	MetalsIBA 01/2020
1	oridoninIBA 01/2019
1	Glutathione (Reduced Glutathione)IBA 01/2019
1	DiterpenesIBA 01/2019
1	Cystine (L-Cystine)IBA 01/2019
1	AntiportersIBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 06/2013
1	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 06/2013
1	Transcription Factors (Transcription Factor)IBA 07/2011
1	plastinIBA 10/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2008
1	Advanced Glycation End ProductsIBA 05/2003
1	Glucose (Dextrose)FDA LinkGeneric 05/2003
1	Transforming Growth Factor beta (TGF-beta)IBA 04/2003

Therapy/Procedure

2	Radiotherapy 01/2022 - 11/2020
1	Photothermal Therapy 07/2022
1	Kidney Transplantation 07/2021
1	Transplantation 07/2021
1	Precision Medicine 01/2021
1	Therapeutics 11/2020
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2019